Researchers attack non-papilloma viruses

A breakthrough vaccine against herpes simplex protected women but not men.

Related Videos
Related Content

Risankizumab Efficacious in Patients with Prior Plaque Psoriasis Biologic Use

March 22nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Roflumilast Safe and Efficient for Patients with Chronic Plaque Psoriasis

March 22nd 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

New Guidelines to Prevent Food Allergies in Pediatric Atopic Dermatitis Patients

March 21st 2023

Phase 3 Data for Bimekizumab Shows Well Maintained Response

March 21st 2023

Risankizumab Efficacious in Patients with Prior Plaque Psoriasis Biologic Use

March 22nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Roflumilast Safe and Efficient for Patients with Chronic Plaque Psoriasis

March 22nd 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

New Guidelines to Prevent Food Allergies in Pediatric Atopic Dermatitis Patients

March 21st 2023

Phase 3 Data for Bimekizumab Shows Well Maintained Response

March 21st 2023

Risankizumab Efficacious in Patients with Prior Plaque Psoriasis Biologic Use

March 22nd 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Roflumilast Safe and Efficient for Patients with Chronic Plaque Psoriasis

March 22nd 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

New Guidelines to Prevent Food Allergies in Pediatric Atopic Dermatitis Patients

March 21st 2023

Phase 3 Data for Bimekizumab Shows Well Maintained Response

March 21st 2023
© 2023 MJH Life Sciences

All rights reserved.